Author

Elliott K. Miller

Observed name: Elliott K Miller

Institution: New Mexico VA Health Care System

Observed institutions: United States Department of Veterans Affairs, University of New Mexico, New Mexico VA Health Care System

ORCID: 0000-0002-7395-9197

Observed ORCID: 0000-0002-7395-9197

OpenAlex ID: A5005111340

Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer

2019 · Lukai Zhai, Rashi Yadav, et al. · Antiviral Research · 64

Inhaled therapeutics against TB: The promise of pulmonary treatment and prevention strategies in the clinic

2019 · Dominique N. Price, Nitesh K. Kunda, et al. · CRC Press eBooks · 5

Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise

2023 · Edward N. Janoff, Sheldon T. Brown, et al. · Contemporary Clinical Trials Communications · 3

Designing and implementing methodology for double-blind, placebo-controlled clinical trials using blood products within the Department of Veterans Affairs

2022 · Elliott K Miller, Alexa M Goldberg, et al. · Clinical Trials · 3

Impact of High‐Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS‐CoV‐2 Infection: VA CoronavirUs Research and Efficacy Studies‐1 (VA CURES‐1)

2025 · Edward N. Janoff, Mei‐Chiung Shih, et al. · Journal of Medical Virology

Strategies to Combat Drug-resistant Tuberculosis: Inhalable Microparticles Formulated With Anti-tubercular Antibiotics and Efflux Pump Inhibitors

2019 · Elliott K. Miller · UNM’s Digital Repository (University of New Mexico)

Works count: 6

Citation count: 75

H-index: 3

I10-index: 1